Last reviewed · How we verify
matching placebo injections
Matching placebo injections are used to compare the efficacy of a new drug to a placebo.
Matching placebo injections are used to compare the efficacy of a new drug to a placebo. Used for Comparing the efficacy of a new drug to a placebo.
At a glance
| Generic name | matching placebo injections |
|---|---|
| Sponsor | Sun Pharmaceutical Industries Limited |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Matching placebo injections are used to ensure that the new drug being tested is the actual cause of any observed effects, rather than other factors. This is done by creating a control group that receives a placebo that is identical to the new drug in every way except for the active ingredient.
Approved indications
- Comparing the efficacy of a new drug to a placebo
Common side effects
Key clinical trials
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis (PHASE2)
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults (PHASE3)
- A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) (PHASE2)
- A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) (PHASE3)
- A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (PHASE2, PHASE3)
- A Study of Barzolvolimab in Patients With Atopic Dermatitis (PHASE2)
- A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition (PHASE3)
- Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- matching placebo injections CI brief — competitive landscape report
- matching placebo injections updates RSS · CI watch RSS
- Sun Pharmaceutical Industries Limited portfolio CI